Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Triwira Insanlestari Tbk. (TRIL)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Triwira Insanlestari Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Triwira Insanlestari Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 60 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TRIL | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 60 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Triwira Insanlestari Tbk.
PT Triwira Insanlestari Tbk (the company) was established on 26 Oct 1992 based on Notaries Deed No. 185 of Erny Tjandrasasmita, S.H.The Companys articles of association has been amended several times, most recently by notarial deed No. 6 of Lenny Janis Ishak, S.H., dated Sep 17, 2007, concerning among others, the change company's name, par value and public offering.
Selengkapnya di halaman TRIL →
